commit 46569fa389bb2350b5d923f7ab0e9d09817eb4bc
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Mon May 2 10:13:18 2022 +0200

    MAY 2022

diff --git a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml
index 666d934..c435fad 100644
--- a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2022-04-01 05:01:56" version="1.3.16 / 4.1.7 [2022-01-26] (orientdb version)" copyright="Orphanet (c) 2022" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2022-05-01 04:59:01" version="1.3.16 / 4.1.7 [2022-01-26] (orientdb version)" copyright="Orphanet (c) 2022" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="6063">
+  <DisorderList count="6058">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166024</ExpertLink>
@@ -8133,16 +8133,16 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.22</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>6.66</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="293">
-          <Source>9918480[PMID]</Source>
+          <Source>35024668[PMID]</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -8152,7 +8152,7 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.85</ValMoy>
+          <ValMoy>6.96</ValMoy>
           <PrevalenceGeographic id="23949">
             <Name lang="nl">Australia</Name>
           </PrevalenceGeographic>
@@ -74182,14 +74182,14 @@
     <Disorder id="946">
       <OrphaCode>3027</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3027</ExpertLink>
-      <Name lang="nl">Caudale regressie-sequentie</Name>
+      <Name lang="nl">Caudale regressie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="3">
         <Prevalence id="2539">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -74198,12 +74198,50 @@
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16781">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16782">
+          <Source>20734338[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>1.75</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="nl">Australia</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -82623,38 +82661,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1265">
-      <OrphaCode>946</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=946</ExpertLink>
-      <Name lang="nl">Acrocefalosyndactylie</Name>
-      <DisorderType id="21436">
-        <Name lang="nl">Group of phenomes</Name>
-      </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="nl">Groep van aandoeningen</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="2783">
-          <Source>ORPHANET_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1278">
       <OrphaCode>957</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=957</ExpertLink>
@@ -99304,55 +99310,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1697">
-      <OrphaCode>1533</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1533</ExpertLink>
-      <Name lang="nl">Craniosynostose - fibulaire aplasie-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3180">
-          <Source>4403018[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3181">
-          <Source>ORPHANET_4403018[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="16992">
       <OrphaCode>140874</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140874</ExpertLink>
@@ -101183,7 +101140,7 @@
     <Disorder id="1684">
       <OrphaCode>1517</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1517</ExpertLink>
-      <Name lang="nl">Hypertrichotische osteochondrodysplasie, Cantu-type</Name>
+      <Name lang="nl">Syndroom van Cantú</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -101509,7 +101466,7 @@
     <Disorder id="1683">
       <OrphaCode>1516</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1516</ExpertLink>
-      <Name lang="nl">Craniofaciale dyssynostose</Name>
+      <Name lang="nl">Niet-syndromale bilambdoïde en sagittale craniosynostose</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -115596,7 +115553,7 @@
     <Disorder id="2078">
       <OrphaCode>2196</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2196</ExpertLink>
-      <Name lang="nl">Familiale primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose met ernstige oogbetrokkenheid</Name>
+      <Name lang="nl">Primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose met ernstige oculaire betrokkenheid</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -123784,7 +123741,7 @@
     <Disorder id="2497">
       <OrphaCode>661</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=661</ExpertLink>
-      <Name lang="nl">Syndroom van Ondine</Name>
+      <Name lang="nl">Congenitale centrale hypoventilatie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -142552,7 +142509,7 @@
     <Disorder id="2983">
       <OrphaCode>3366</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3366</ExpertLink>
-      <Name lang="nl">Geïsoleerde trigonocefalie</Name>
+      <Name lang="nl">Niet-syndromale metopische craniosynostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -156202,7 +156159,7 @@
     <Disorder id="3249">
       <OrphaCode>478</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=478</ExpertLink>
-      <Name lang="nl">Kallmannsyndroom</Name>
+      <Name lang="nl">Syndroom van Kallmann</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -165848,7 +165805,7 @@
     <Disorder id="18746">
       <OrphaCode>213528</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=213528</ExpertLink>
-      <Name lang="nl">Zeldzaam adenocarcinoom van de borst</Name>
+      <Name lang="nl">Zeldzaam adenocarcinoom van borst</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188810,7 +188767,7 @@
     <Disorder id="19334">
       <OrphaCode>240103</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=240103</ExpertLink>
-      <Name lang="nl">Progressieve supranucleaire paralyse - corticobasaal parkinsonisme</Name>
+      <Name lang="nl">Progressieve supranucleaire paralyse - corticobasaal syndroom</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -188842,7 +188799,7 @@
     <Disorder id="19333">
       <OrphaCode>240094</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=240094</ExpertLink>
-      <Name lang="nl">Progressieve supranucleaire paralyse - zuivere akinesie met bevroren gang-syndroom</Name>
+      <Name lang="nl">Progressieve supranucleaire paralyse - zuivere akinesie met gangblokkade-syndroom</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -190778,55 +190735,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="21931">
-      <OrphaCode>329341</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329341</ExpertLink>
-      <Name lang="nl">Limbische encefalitis met DPP6-antilichamen</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="10180">
-          <Source>23225603[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10181">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="21911">
       <OrphaCode>329228</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329228</ExpertLink>
@@ -192974,7 +192882,7 @@
     <Disorder id="21781">
       <OrphaCode>324525</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324525</ExpertLink>
-      <Name lang="nl">Hypertrofische cardiomyopathie en renale tubulaire ziekte door mitochondriale DNA-mutatie</Name>
+      <Name lang="nl">Hypertrofische cardiomyopathie met nieranomalieën door mutatie van mitochondriaal DNA</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -210022,7 +209930,7 @@
     <Disorder id="5533">
       <OrphaCode>890</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=890</ExpertLink>
-      <Name lang="nl">Hepatische veno-occlusieve ziekte</Name>
+      <Name lang="nl">Veno-occlusieve ziekte van lever</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -214948,7 +214856,7 @@
     <Disorder id="21494">
       <OrphaCode>314555</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314555</ExpertLink>
-      <Name lang="nl">Faciale dysmorfie - ernstige myopie - osteopenie - intellectuele achterstand - dentale anomalieën-syndroom</Name>
+      <Name lang="nl">Faciale dysmorfie - oculaire anomalieën - osteopenie - intellectuele achterstand - dentale anomalieën-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -218918,7 +218826,7 @@
     <Disorder id="21222">
       <OrphaCode>306516</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306516</ExpertLink>
-      <Name lang="nl">Familiale primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose</Name>
+      <Name lang="nl">Primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -225386,7 +225294,7 @@
     <Disorder id="7024">
       <OrphaCode>629</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=629</ExpertLink>
-      <Name lang="nl">Kleine gestalte als gevolg van groeihormoonkwaliteitanomalie</Name>
+      <Name lang="nl">Kleine gestalte door kwalitatieve anomalie van groeihormoon</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -265668,55 +265576,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="25936">
-      <OrphaCode>498700</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=498700</ExpertLink>
-      <Name lang="nl">Limbische encefalitis met neurexine-3 antilichamen</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13782">
-          <Source>27170573[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13783">
-          <Source>ORPHANET_27170573[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="8594">
       <OrphaCode>874</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=874</ExpertLink>
@@ -272092,7 +271951,7 @@
     <Disorder id="9284">
       <OrphaCode>31043</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=31043</ExpertLink>
-      <Name lang="nl">Familiale primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose zonder ernstige oculaire betrokkenheid</Name>
+      <Name lang="nl">Primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose zonder ernstige oculaire betrokkenheid</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -272548,7 +272407,7 @@
     <Disorder id="10993">
       <OrphaCode>71271</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71271</ExpertLink>
-      <Name lang="nl">Split hand-split foot-deafness syndrome</Name>
+      <Name lang="nl">Gespleten hand - gespleten voet - doofheid-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -279297,38 +279156,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="10822">
-      <OrphaCode>63440</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=63440</ExpertLink>
-      <Name lang="nl">Geïsoleerde oxycefalie</Name>
-      <DisorderType id="21415">
-        <Name lang="nl">Morfologische anomalie</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="5872">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="10823">
       <OrphaCode>63442</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=63442</ExpertLink>
@@ -280423,7 +280250,7 @@
     <Disorder id="28399">
       <OrphaCode>564178</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=564178</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie met refractaire insulten en intellectuele achterstand</Name>
+      <Name lang="nl">Primaire hypomagnesiëmie - refractaire insulten - intellectuele achterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -283271,7 +283098,7 @@
     <Disorder id="11175">
       <OrphaCode>79149</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79149</ExpertLink>
-      <Name lang="nl">Dermo-chondro-corneale dystrofie</Name>
+      <Name lang="nl">Dermochondrocorneale dystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -283610,7 +283437,7 @@
     <Disorder id="11185">
       <OrphaCode>79159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79159</ExpertLink>
-      <Name lang="nl">Isobutyryl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van isobutyryl-CoA-dehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -284511,7 +284338,7 @@
     <Disorder id="11166">
       <OrphaCode>79140</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79140</ExpertLink>
-      <Name lang="nl">Cutaan neuroendocrien carcinoom</Name>
+      <Name lang="nl">Cutaan neuro-endocrien carcinoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -285884,7 +285711,7 @@
     <Disorder id="11125">
       <OrphaCode>79076</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79076</ExpertLink>
-      <Name lang="nl">Juveniele polyposis bij jonge kinderen</Name>
+      <Name lang="nl">Juveniele polyposis beginnend in de zuigelingentijd</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -288992,7 +288819,7 @@
     <Disorder id="11036">
       <OrphaCode>73224</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73224</ExpertLink>
-      <Name lang="nl">Tubulaire nefropathie - cardiomyopathie-syndroom</Name>
+      <Name lang="nl">Tubulopathie van nier - gedilateerde cardiomyopathie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -304217,7 +304044,7 @@
     <Disorder id="11913">
       <OrphaCode>89938</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=89938</ExpertLink>
-      <Name lang="nl">Infantiel syndroom van Bartter met sensorineurale doofheid</Name>
+      <Name lang="nl">Syndroom van Bartter type 4</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -306405,7 +306232,7 @@
     <Disorder id="11817">
       <OrphaCode>88639</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88639</ExpertLink>
-      <Name lang="nl">Neurodegeneratie als gevolg van 3-hydroxyisobutyryl-CoA-hydrolasedeficiëntie</Name>
+      <Name lang="nl">Neurodegeneratie door deficiëntie van 3-hydroxyisobutyryl-CoA-hydrolase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -310700,7 +310527,7 @@
     <Disorder id="12252">
       <OrphaCode>93315</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93315</ExpertLink>
-      <Name lang="nl">Spondylometafysaire dysplasie, 'hoekfractuur'-type</Name>
+      <Name lang="nl">Spondylometafysaire dysplasie, hoekfractuur-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -311209,7 +311036,7 @@
     <Disorder id="12095">
       <OrphaCode>90791</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90791</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie door 3-bèta-hydroxysteroïdedehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van 3-bèta-hydroxysteroïdedehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -312581,7 +312408,7 @@
     <Disorder id="12153">
       <OrphaCode>91494</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91494</ExpertLink>
-      <Name lang="nl">Maculacoloboom - gespleten verhemelte - hallux valgus-syndroom</Name>
+      <Name lang="nl">Maculacoloboom - gespleten gehemelte - hallux valgus-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -313403,7 +313230,7 @@
     <Disorder id="12098">
       <OrphaCode>90795</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90795</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie door 11-bèta-hydroxylasedeficiëntie</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van 11-bèta-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -320728,7 +320555,7 @@
     <Disorder id="11649">
       <OrphaCode>85191</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85191</ExpertLink>
-      <Name lang="nl">Singleton-Mertendysplasie</Name>
+      <Name lang="nl">Dysplasie, Singleton-Merten-type</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -321610,7 +321437,7 @@
     <Disorder id="11670">
       <OrphaCode>85280</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85280</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand, X-gebonden - cubitus valgus - dysmorfie</Name>
+      <Name lang="nl">X-gebonden intellectuele achterstand - cubitus valgus - dysmorfie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -324252,7 +324079,7 @@
     <Disorder id="11741">
       <OrphaCode>86821</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86821</ExpertLink>
-      <Name lang="nl">Lissencefalie type 3 - familiale foetale akinesiesequentie-syndroom</Name>
+      <Name lang="nl">Lissencefalie type 3 - familiale foetale akinesie sequentie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -324301,7 +324128,7 @@
     <Disorder id="11742">
       <OrphaCode>86822</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86822</ExpertLink>
-      <Name lang="nl">Lissencefalie type 3 - metacarpaalbotdysplasie</Name>
+      <Name lang="nl">Lissencefalie type 3 - dysplasie van metacarpus-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -329357,7 +329184,7 @@
     <Disorder id="11629">
       <OrphaCode>85162</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85162</ExpertLink>
-      <Name lang="nl">Sensorische en motorische neuronopathie met faciale aanvang</Name>
+      <Name lang="nl">Sensorische en motorische neuropathie met faciale aanvang</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329723,7 +329550,7 @@
     <Disorder id="11619">
       <OrphaCode>84142</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=84142</ExpertLink>
-      <Name lang="nl">Syndroom van Isaac</Name>
+      <Name lang="nl">Syndroom van Isaacs</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -330341,7 +330168,7 @@
     <Disorder id="11632">
       <OrphaCode>85165</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85165</ExpertLink>
-      <Name lang="nl">Ernstige achondroplasie - ontwikkelingsachterstand - acanthosis nigricans</Name>
+      <Name lang="nl">Ernstige achondroplasie - ontwikkelingsachterstand - acanthosis nigricans-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -331832,7 +331659,7 @@
     <Disorder id="12896">
       <OrphaCode>97340</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97340</ExpertLink>
-      <Name lang="nl">Hunter-McAlpine craniosynostose</Name>
+      <Name lang="nl">Syndroom van Hunter-McAlpine</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -334058,7 +333885,7 @@
     <Disorder id="12654">
       <OrphaCode>95699</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95699</ExpertLink>
-      <Name lang="nl">Congenitale hyperplasie van bijnier door deficiëntie van cytochroom P450-oxidoreductase</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van cytochroom P450-oxidoreductase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -339880,7 +339707,7 @@
     <Disorder id="12438">
       <OrphaCode>93605</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93605</ExpertLink>
-      <Name lang="nl">Klassiek syndroom van Bartter</Name>
+      <Name lang="nl">Syndroom van Bartter type 3</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -355843,7 +355670,7 @@
     <Disorder id="28672">
       <OrphaCode>570371</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=570371</ExpertLink>
-      <Name lang="nl">Transiënt prenataal syndroom van Bartter</Name>
+      <Name lang="nl">Syndroom van Bartter type 5</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
